Since 2011 leaders in the Extracellular Vesicles field

Harnessing the Power of Exosomes

From Exosomes to Insight

Rivela Diagnostics

The only company focusing on early pan-cancer diagnostics based on a technology using exosomes as vehicles of cancer metabolic biomarkers. We envisions a world in which a simple blood drop will be sufficient for early multi-cancer screening, easier patients' profiling and monitoring and, ultimately, better people and patients lives.


The only exosome focused company selling globally the largest variety of standards, reagents and products for EV research, and providing a large variety of services including EVs isolation, characterization, early R&D projects and pilot studies.


Information on the cookies present on this site

This site uses anonymous technical and statistical cookies, necessary for its operation.

Read more x